• Home
  •  / Reneuron Group

Reneuron Group

OverviewSuggest Edit

ReNeuron is a leading, UK-based stem cell company. Our primary objective is the development of stem cell therapies targeting areas of significant unmet or poorly met medical need
TypePublic
Founded1997
HQPencoed, GBMap
Websitereneuron.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Sept 2017)53(+21%)
Revenue (FY, 2019)£49 K(+14%)
Share Price (Jan 2021)£1.2 (-7%)
Cybersecurity ratingBMore

Key People/Management at Reneuron Group

Olav Hellebo

Olav Hellebo

Chief Executive Officer
Simon Cartmell

Simon Cartmell

Non-Executive Director
Richard Beckman

Richard Beckman

Chief Medical Officer
Tim Corn

Tim Corn

Chairman
Shaun Stapleton

Shaun Stapleton

Vice President Regulatory Affairs and Pharmacovigilence
Mark Evans

Mark Evans

Non-Executive Director
Show more

Reneuron Group Office Locations

Reneuron Group has offices in Pencoed and Surrey Research Park
Pencoed, GB (HQ)
Pencoed Business Park
Surrey Research Park, GB
10 Nugent Rd
Show all (2)

Reneuron Group Financials and Metrics

Reneuron Group Revenue

Reneuron Group's revenue was reported to be £49 k in FY, 2019
GBP

Revenue (FY, 2019)

49.0k

Net income (FY, 2019)

(14.3m)

EBITDA (FY, 2019)

(18.0m)

EBIT (FY, 2019)

(18.3m)

Market capitalization (20-Jan-2021)

70.8m

Closing stock price (20-Jan-2021)

1.2

Cash (31-Mar-2019)

20.4m
Reneuron Group's current market capitalization is £70.8 m.
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

3.0k9.0k49.0k27.0k93.0k31.0k29.0k40.0k17.0k22.030.0k29.0k46.0k43.0k49.0k

Revenue growth, %

36%(3%)

Operating expense total

3.4m(5.9m)6.0m6.9m4.8m6.2m6.9m7.1m8.0k10.4m13.8m19.9m20.4m18.3m

EBITDA

(5.8m)(6.7m)(4.5m)(3.9m)(6.7m)(7.0m)(7.9k)(10.3m)(13.7m)(18.2m)(20.1m)(18.0m)
show all
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

70.0k5.1m7.7m2.8m943.0k5.5m9.7m4.0m3.5m14.9k12.4m17.4m53.1m27.9m20.4m

Accounts Receivable

386.0

Current Assets

1.1m6.2m8.7m3.2m2.0m6.2m10.5m5.1m4.6m22.3k14.1m64.9m58.1m41.7m30.0m

PP&E

1.4m1.2m1.0m1.0m834.0k541.0k419.0k298.0k213.0k225.0161.0k361.0k724.0k726.0k632.0k
show all
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(3.2m)(6.3m)(5.2m)(6.6m)(3.7m)(5.8m)(6.1m)(6.2m)(6.3m)(7.1k)(8.9m)(11.4m)(15.6m)(17.6m)(14.3m)

Cash From Operating Activities

3.2m5.0m6.0m(6.1m)(4.4m)(2.6m)(5.1m)(5.8m)(6.0m)(6.0k)(8.2m)(11.9m)(12.6m)(14.9m)(12.0m)

Cash From Financing Activities

1.0m9.3m7.9m1.2m2.5m7.2m9.3m91.0k5.6m17.4k6.0m16.9m23.3m14.5m4.4m

Net Change in Cash

62.0k5.1m2.5m(4.9m)(1.8m)4.6m4.1m(5.7m)(436.0k)11.4k(2.5m)5.0m10.7m(214.0k)(7.5m)
show all
GBPFY, 2005

Financial Leverage

-1.3 x
Show all financial metrics

Reneuron Group Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

Learn more about our premium products
SecurityScorecard logo

Reneuron Group Online and Social Media Presence

Reneuron Group's Trends

Embed Graph

Reneuron Group News and Updates

February 20, 2019

ReNeuron Group plc Announces Positive Preliminary Data in U.S. Retinitis Pigmentosa Trial

LONDON, Feb. 20, 2019 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announced positive preliminary results in the Company's ongoing Phase 1/2 clinical trial of its human retinal progenitor cells (hRPC) cell therapy...
July 13, 2018

Reneuron Group Plc. 2018 Q4 - Results - Earnings Call Slides

 Reneuron Group Frequently Asked Questions

  • When was Reneuron Group founded?

    Reneuron Group was founded in 1997.

  • Who are Reneuron Group key executives?

    Reneuron Group's key executives are Olav Hellebo, Simon Cartmell and Richard Beckman.

  • How many employees does Reneuron Group have?

    Reneuron Group has 53 employees.

  • What is Reneuron Group revenue?

    Latest Reneuron Group annual revenue is £49 k.

  • What is Reneuron Group revenue per employee?

    Latest Reneuron Group revenue per employee is £925 .

  • Who are Reneuron Group competitors?

    Competitors of Reneuron Group include Eloxx Pharmaceuticals, Personal Genome Diagnostics (PGD) and Touchlight Genetics.

  • Where is Reneuron Group headquarters?

    Reneuron Group headquarters is located at Pencoed Business Park, Pencoed.

  • Where are Reneuron Group offices?

    Reneuron Group has offices in Pencoed and Surrey Research Park.

  • How many offices does Reneuron Group have?

    Reneuron Group has 2 offices.